The University of Cambridge under partnership with Department of Biotechnology (DBT) has invited applications for five fixed-term, research-oriented University Lectureships.
The move is aimed to strengthen the University's strategic relationship with Indian research institutions and to enhance academic, research and translational capacities of India and the UK.
Hilleman Laboratories scientist Dr. Ankur Mutreja has been awarded the prestigious position at the University of Cambridge under the esteemed "DBT Cambridge Lectureship" programme.
Dr. Mutreja, who has been with Hilleman Laboratories, leading the company's ETEC vaccine project, is elated on being awarded this highly coveted role.
Expressing his views, Dr. Ankur Mutreja said, "I am humbled to receive this honour and grateful to the University of Cambridge and the Department of Biotechnology, GoI for considering me for this prestigious position. I would also like to express my gratitude to Hilleman Laboratories for providing me a stimulating and highly motivating environment to enhance my knowledge and expertise through advanced research. I look forward to my continued association with the organisation."
This development is a testimony to Hilleman Laboratories philosophy of providing world-class infrastructure and environment that nurtures talent, especially in the field of biotechnology and Vaccine R and D, India Today reported.